Table 4 F1 scores for the IAA on complex entities in the glaucoma-T2DM corpus of 20 abstracts. Slot-fillers that contain reference to other complex entities are in italics and single entity slot-fillers in normal font
Publication | F1 | Population | F1 |
|---|---|---|---|
hasAuthor | 0.87 | hasCountry | 0.84 |
hasTitle | 1.00 | hasAvgAge | 1.00 |
hasJournal | 0.97 | hasMinAge | 1.00 |
hasPublicationYear | 0.95 | hasPrecondition | 0.86 |
hasPMID | 0.97 | hasMaxAge | 1.00 |
describes | 1.00 | hasGender | 1.00 |
ClinicalTrial | F1 | DiffBetweenGroups | F1 |
hasNumberPatientsCT | 1.00 | hasDiffGroupAbsValue | 1.00 |
analysesHealthCondition | 0.78 | hasDiffGroupRelValue | 0.86 |
hasConclusionComment | 0.96 | hasConfIntervalDiff | 1.00 |
hasFinalNumberPatientsCT | 1.00 | hasPvalueDiff | 0.87 |
hasObjectiveDescription | 1.00 | hasStandardDevDiff | 1.00 |
hasAnalysisApproach | 1.00 | hasOutcome1 | 0.65 |
hasCTDesign | 0.98 | hasOutcome2 | 0.59 |
hasCTduration | 0.94 | Â | Â |
hasArm | 1.00 | Â | Â |
hasDiffBetweenGroups | 0.89 | Â | Â |
hasPopulation | 0.97 | Â | Â |
Arm | F1 | Intervention | F1 |
hasNumberPatientsArm | 1.00 | hasFrequency | 0.95 |
hasAdverseEffect | 0.32 | hasRelativeFreqTime | 0.94 |
hasIntervention | 0.60 | hasInterval | 0.67 |
hasOutcome | 0.60 | hasMedication | 0.69 |
Medication | F1 | Endpoint | F1 |
hasDrug | 0.83 | hasEndoPointDescription | 0.82 |
hasDeliveryMethod | 0.40 | hasBaselineUnit | 0.81 |
hasDoseUnit | 0.92 | Â | Â |
hasDoseValue | 0.89 | Â | Â |
hasDoseDescription | 0.86 | Â | Â |
Outcome | F1 | Outcome (cont.) | F1 |
hasBaselineValue | 0.84 | hasChangeValue | 1.00 |
hasConfIntervalChangeValue | 1.00 | hasNumberAffected | 1.00 |
hasObservedResult | 0.81 | hasPercentageAffected | 0.93 |
hasPValueChangeValue | 1.00 | hasPValueResValue | 1.00 |
hasRelativeChangeValue | 1.00 | hasResultMeasuredValue | 1.00 |
hasSdDevChangeValue | 1.00 | hasSdErrorChangeValue | 1.00 |
hasSdDevBL | 0.93 | hasSdDevResValue | 1.00 |
hasSubGroupDescription | 1.00 | hasTimePoint | 0.69 |
hasEndpoint | 0.66 | Â | Â |